|
1
|
Bousquet J, Khaltaev N, Cruz AA, Denburg
J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica
GW, van Weel C, et al: Allergic Rhinitis and its Impact on Asthma
(ARIA) 2008 update (in collaboration with the World Health
Organization, GA(2)LEN and AllerGen). Allergy. 63:8–160. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Lin L and Zheng C: Downregulation
of Orai1 expression in the airway alleviates murine allergic
rhinitis. Exp Mol Med. 44:177–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosati MG and Peters AT: Relationships
among allergic rhinitis, asthma and chronic rhinosinusitis. Am J
Rhinol Allergy. 30:44–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Settipane RA and Schwindt C: Chapter 15:
Allergic rhinitis. Am J Rhinol Allergy. 27 (Suppl 1):S52–S55. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sur DK and Plesa ML: Treatment of allergic
rhinitis. Am Fam Physician. 92:985–992. 2015.PubMed/NCBI
|
|
6
|
Bernstein DI, Schwartz G and Bernstein JA:
Allergic rhinitis: Mechanisms and treatment. Immunol Allergy Clin
North Am. 36:261–278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andersson M, Greiff L, Ojeda P and Wollmer
P: Barrier-enforcing measures as treatment principle in allergic
rhinitis: a systematic review. Curr Med Res Opin. 30:1131–1137.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steelant B, Farré R, Wawrzyniak P, Belmans
J, Dekimpe E, Vanheel H, Van Gerven L, Kortekaas Krohn I, Bullens
DMA, Ceuppens JL, et al: Impaired barrier function inpatients with
house dust mite-induced allergic rhinitis is accompanied
bydecreased occludin and zonula occludens-1 expression. J. Allergy
Clin.Immunol. 137:1043–1053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang DY: Risk factors of allergic
rhinitis: Genetic or environmental? Ther Clin Risk Manag.
1:115–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ciprandi G, Marseglia GL, Castagnoli R,
Valsecchi C, Tagliacarne C, Caimmi S and Licari A: From IgE to
clinical trials of allergic rhinitis. Expert Rev Clin Immunol.
11:1321–1333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hashimoto C Hudson KL and Anderson KV: The
toll gene of Drosophila, required for dorsal-ventral embryonic
polarity, appears to encode a transmembrane protein. Cell.
52:269–279. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lemaitre B Nicolas E, Michaut L, Reichhart
JM and Hoffmann JA: The dorsoventral regulatory gene cassette
spätzle/Toll/cactus controls the potent antifungal response in
Drosophila adults. Cell. 86:973–983. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll protein
signals activation of adaptive immunity. Nature. 388:394–397. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwasaki A and Medzhitov R: Regulation of
adaptive immunity by the immune system. Science. 327:291–295. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takeda K, Kaisho T and Akira S: Toll-like
receptors. Annu Rev Immuno1. 21:335–376. 2003. View Article : Google Scholar
|
|
17
|
Molteni M, Gemma S and Rossetti C: The
role of toll-like receptor 4 in infectious and noninfectious
inflammation. Mediators Inflamm. 2016:69789362016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beutler B: TLR4 as the mammalian endotoxin
sensor. Curr Top Microbiol Immunol. 270:109–120. 2002.PubMed/NCBI
|
|
19
|
Beutler B, Du X and Poltorak A:
Identification of toll-like receptor 4 (TLR4) as the sole conduit
for LPS signal transduction: Genetic and evolutionary studies. J
Endotoxin Res. 7:277–280. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garibotto G, Carta A, Picciotto D, Viazzi
F and Verzola D: Toll-like receptor-4 signaling mediates
inflammation and tissue injury in diabetic nephropathy. J Nephrol.
30:719–727. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maglione PJ, Simchoni N and
Cunningham-Rundles C: Toll-like receptor signaling in primary
immune deficiencies. Ann N Y Acad Sci. 1356:1–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong L, Li H, Wang S and Li Y: Different
doses of lipopolysaccharides regulate the lung inflammation of
asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma.
46:229–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peters M, Dudziak K, Stiehm M and Bufe A:
T-cell polarization depends on concentration of the danger signal
used to activate dendritic cells. Immunol Cell Biol. 88:537–544.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takabayashi K, Libet L, Chisholm D,
Zubeldia J and Horner AA: Intranasal immunothcrapy is more
effective than intradcrmal immunotherapy for the induction of
air-way allergen tolerance in Th2-sensitized mice. J Immunol.
170:3898–3905. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cui XY, Chen X, Yu CJ, Yang J, Lin ZP, Yin
M and Cheng L: Increased expression of toll-like receptors 2 and 4
and related cytokines in persistent allergic rhinitis. Otolaryngol
Head Neck Surg. 152:233–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao L, Jiang L, Hu Q and Li Y:
MicroRNA-133b ameliorates allergic inflammation and symptom in
murine model of allergic rhinitis by targeting Nlrp3. Cell Physiol
Biochem. 42:901–912. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan Y, Liu Q, Zhao J, Tang H and Sun J:
SIRT1 attenuates murine allergic rhinitis by downregulated HMGB
1/TLR4 pathway. Scand J Immunol. 87:e126672018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Casale TB and Dykewicz MS: Clinical
implications of the allergic rhinitis-asthma link. Am J Med Sci.
327:127–138. 2014. View Article : Google Scholar
|
|
30
|
Brożek JL, Bousquet J, Agache I, Agarwal
A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R,
Canonica GW, Casale T, Chavannes NH, et al: Allergic Rhinitis and
its Impact on Asthma (ARIA) guidelines:evision. J Allergy Clin
Immunol. 140:950–958. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Izquierdo-Domínguez A, Valero AL and
Mullol J: Comparative analysis of allergic rhinitis in children and
adults. Curr Allergy Asthma Rep. 13:142–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shimazu R, Akashi S, Ogata H, Nagai Y,
Fukudome K, Miyake K and Kimoto M: MD-2, a molecule that confers
lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp
Med. 189:1777–1782. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rifkin IR, Leadbetter EA, Busconi L,
Viglianti G and Marshak-Rothstein A: Toll-like receptors,
endogenous ligands and systemic autoimmune disease. Immunol Rev.
204:27–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang JY and Lee JO: Structural biology of
the Toll-like receptor family. Annu Rev Biochem. 80:917–941. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peri F and Calabrese V: Toll-like receptor
4 (TLR4) modulation by synthetic and natural compounds an update. J
Med Chem. 57:3612–3622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhong JJ, Wan YY, Diao YW, et al: The
research development of Toll-like receptors targeted drugs. Chin
Bull Life Dci. 27:439–444. 2015.(In Chinese).
|
|
37
|
Sasai M and Yamamoto M: Pathogen
recognition receptors: Ligands and signaling pathways by Toll-like
receptors. Int Rev Immunol. 32:116–133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fuertes E, Brauer M, MacIntyre E, Bauer M,
Bellander T, von Berg A, Berdel D, Brunekreef B, Chan-Yeung M,
Gehring U, et al: Childhood allergic rhinitis, traffic-related air
pollution and variability in the GSTP1, TNF, TLR2 and TLR4 genes:
Results from the TAG study. J Allergy Clin Immunol. 132:342–352.e2.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Radman M, Golshiri A, Shamsizadeh A,
Zainodini N, Bagheri V, Arababadi MK and Kennedy D: Toll-like
receptor 4 plays significant roles during allergic rhinitis.
Allergol Immunopathol (Madr). 43:416–420. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhong H, Fan XL, Yu QN, Qin ZL, Chen D, Xu
R, Chen DH, Lin ZB, Wen W and Fu QL: Increased innate type 2 immune
response in house dust mite-allergic patients with
allergicrhinitis. Clin Immunol. 183:293–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Madore AM and Laprise C: Immunological and
genetic aspects of asthma and allergy. J Asthma Allergy. 3:107–121.
2010.PubMed/NCBI
|
|
42
|
Galli SJ and Tsai M: IgE and mast cells in
allergic disease. Nat Med. 18:693–704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Metcalfe DD, Pawankar R, Ackerman SJ, Akin
C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion
AD, et al: Biomarkers of the involvement of mast cells, basophils
and eosinophils in asthma and allergic diseases. World Allergy
Organ J. 9:72016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fujitani Y, Kanaoka Y, Aritake K, Uodome
N, Okazaki-Hatake K and Urade Y: Pronounced eosinophilic lung
inflammation and Th2 cytokine release in human lipocalin-type
prostaglandin D synthase transgenic mice. J Immunol. 168:443–449.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bae JS, Kim JH, Kim EH and Mo JH: The role
of IL-17 in a lipopolysaccharide-induced rhinitis model. Allergy
Asthma Immunol Res. 9:169–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Eswarappa SM, Basu N, Joy O and
Chakravortty D: Folimycin (concanamycin A) inhibits LPS-induced
nitric oxide production and reduces surface localization of TLR4 in
murine macrophages. Innate Immun. 14:13–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
